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of Health Sciences at Purdue 
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obtained his BS degree from 
Worcester Polytechnic Institute 
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in 2007 and his PhD degree from Baylor College 
of Medicine in translational biology and molecular 
medicine in 2012. As a postdoctoral researcher 
at Washington University in St. Louis, he helped 
validate and characterize a mouse model of radiation 
necrosis, a late-onset side effect of radiation  
therapy that mimics a tumor on standard anatomical 
MRI. As a faculty member at Purdue University,  
Dr. Pérez-Torres continues to focus on how radiation 
treatment affects the normal brain to develop 
better diagnostic MRI tools (is it a tumor or just a 
treatment side effect?) and to potentially improve 
radiation therapy of brain tumors.
DEVELOPING DRUG THERAPIES: 








Pediatric brain cancer patients are at a 
high risk for radiation-induced cognitive 
impairment due to white matter changes in 
the brain. Half of six-month radiotherapy 
survivors develop signifi cant changes 
in white matter. Previous research has 
shown that a mouse model can be used 
to show similar cognitive and behavioral 
defi cits in human patients. The purpose of 
this work is to evaluate the eff ectiveness 
of two drug therapies, Donepezil and 
3,3-Diindolylmethane (DIM), that could be 
used to either protect the brain from radiation 
injury or cure the cognitive injury and 
behavioral defi cits that result from whole-
brain irradiation. This project consisted 
of two parts: administration of Donepezil 
postradiation as a symptomatic cure and 
administration of DIM before radiation as 
a protectant. The mice received 30 gray 
whole brain radiation, and their behavioral 
changes were measured at 4 and 8 weeks 
postradiation. Behavioral changes were 
observed using two tests: the Open Field Test 
and Marble Burying Test. These tests were 
to see if the treated mice would have results 
closer to the healthy baselines established 
in previous research. From our data, we 
observed Donepezil to be an ineff ective form 
of therapy, as the defi cits did not improve. 
However, DIM has shown to be a promising 
protectant drug therapy, as the behavioral data 
is closer to the results of a healthy control. 
This research validates the potential of DIM 
to be used as a radio protectant in preventing 
both radiation injury and any cognitive 
defi cits from following.
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GOALS AND AIMS OF THE PROJECT
Over the past four years, my work under Dr. 
Carlos Perez-Torres has focused on evaluating the 
neurocognitive eff ects of radiation on the brain using 
a mouse model. During my freshman year, our fi rst 
goal was to identify when late cognitive eff ects 
are seen in the brain and understand the extent of 
damage induced from radiation. We also wanted to 
fi nd an appropriate radiation dosage that would allow 
us to model brain damage clearly in a mouse.
We started off  by radiating female mice 
approximately 5–6 weeks old, mimicking a human 
pediatric brain, with fi ve diff erent radiation dosages 
of 10, 15, 20, 25, and 30 gray onetime treatment, 
by use of a linear accelerator. For comparison, the 
standard therapy dosage for humans ranges from 
about 14 to 24 Gy for brain metastases (Timmerman, 
2008). Then, we monitored the eff ects of radiation on 
these brains at diff erent time points postradiation by 
euthanizing diff erent groups of mice at 1 hour or 4, 
8, 12, or 16 weeks. We analyzed the damage to the 
brain by using immunohistochemistry to stain brain 
tissue for diff erent kinds of damage. Results showed 
that 30 Gy was the dosage most eff ective in showing 
consistent damage and that damage was the worst at 
8 and 16 weeks postradiation.
Next, we investigated the diff erences between male 
and female mice in their response to radiation. 
Initially, the assumption supported by other research 
showed that female mice were more susceptible to 
radiation than male mice. So, females would make 
better models, as their sensitivity would show the 
eff ects of injury quite clearly. However, we could 
not assume that what we were seeing in female 
mice would be exactly what we might see in male 
mice. To do this, we radiated both female and male 
mice with the same dosages of radiation and then 
used immunohistochemistry to compare the injury 
between the two sexes. We found that females and 
males showed radiation injury in diff erent ways. The 
males showed more injury at a later time point, while 
the females were more susceptible to the eff ects of 
radiation earlier on.
After establishing reliable methods where we could 
consistently model radiation damage in mice, we 
wanted to further explore the extent of cognitive 
damage. The cognitive damage is best observed 
as behavioral changes. Our primary question was 
whether mice that received brain radiation developed 
the same cognitive and behavioral changes as seen in 
human patients.
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In order to track the behavioral changes, we first 
had to pick behavioral tests to accurately and 
consistently show these changes. The Open Field 
and Marble Burying Tests were chosen for their 
ability to measure normal mouse behaviors, anxiety, 
and cognitive ability. Both behavioral tests showed 
a significant cognitive decline in the mice after 
receiving radiation. The behavioral impairments 
increased with time, as supported by pathology.
All of this work has led to my final senior project: 
developing drug therapies for cognitive damage in 
mice following brain radiation. The purpose of this 
project was to investigate whether drug therapies, 
such as Donepezil and 3,3-Diindolylmethane (DIM), 
can be used in mice to protect from or reverse the 
cognitive damage that results from brain radiation.
BACKGROUND
Cancer today is considered one of the leading causes 
of death around the world, especially for children. 
Brain cancer is among one of those top cancers 
causing death. For adults, recovery from brain 
cancer is uncommon because of how aggressive the 
cancer can be. The survival rate for malignant brain 
tumors in adults is only 35%, while in children the 
survival rate is 74% (“Quick Brain Tumor Facts,” 
n.d.). Radiation is commonly used as an effective 
form of therapy when treating brain tumors. But like 
other treatments such as chemotherapy and surgery, 
radiation comes with risks.
Pediatric brain cancer patients who survive radiation 
therapy are at a high risk for radiation-induced 
cognitive impairment in healthy tissue surrounding 
the tumor due to white matter changes in the brain. 
Unfortunately, about half of six-month radiotherapy 
survivors develop significant changes in white matter, 
potentially leading to significant cognitive changes 
and impairment. Some of the side effects observed 
have been learning deficits, a decrease in IQ, or 
different neurocognitive effects. These side effects 
are rarely seen in adults, because most adults do 
not survive long enough after being diagnosed and 
treated with radiation (Attia et al., 2014). To further 
investigate these effects, a mouse model of radiation 
injury was developed to investigate if mice that 
received brain radiation develop the same cognitive 
and behavioral changes as seen in human patients.
When radiation doses are used for mice, higher 
doses must be used, because mice tend to have a 
higher resistance to the effects of radiation. It is also 
important to keep in mind that humans and mice 
have differences in timing and amount of radiation 
dosage. Human clinical patients are usually radiated 
with about 2 Gy, five days a week. However, to 
mimic that in mice would be extremely expensive 
and time-consuming. So, mice are usually radiated 
with a higher dose one time.
Mouse models can be used to show the changes in 
the brain postradiation, using immunohistochemistry 
to look for pathological changes and behavior tests 
to observe changes in behavior. In human patients, 
behavioral changes include increased anxiety, loss of 
memory, and a decrease in IQ. Increased anxiety and 
memory loss are also behaviors that can be measured 
and observed in mice using the Open Field Test and 
the Marble Burying Test.
Results showed that brain radiation does cause 
behavioral changes, and this injury can be modeled 
in mice to show significant impairments. From 
a pathology standpoint, radiation of healthy 
brain tissue resulted in specific changes in white 
matter consisting of large holes, cell death, and 
inflammatory responses. This pathology produced 
deficits that become more pronounced over time, as 
supported by pathology and behavior tests.
In order to protect from or treat radiation damage 
of healthy tissue, two drug therapies were 
chosen to test—Donepezil and DIM. Donepezil, 
a cognition-enhancing drug used to improve 
memory and attention in Alzheimer’s patients, is a 
central acetylcholinerase inhibitor that is injected 
intraperitonealy (“Donepezil,” n.d.). It is a drug 
therapy that focuses on treating the symptoms but 
cannot cure the underlying disease. Side effects 
include nausea, vomiting, diarrhea, cramps, weight 
loss, and dizziness. DIM is a chemical naturally 
formed in the body by breaking down cruciferous 
vegetables such as broccoli, cauliflower, and cabbage 
and is thought to possibly be a protectant from 
cancer. DIM is a fat-soluble drug that is able to 
cross the blood-brain barrier, which is an essential 
characteristic for this therapy (“Diindolylmethane,” 
n.d.). It is also injected intraperitonealy. Previous 
literature has proven its use as a protection from 
radiation damage to skin (Fan, 2013). The only 
known side effects of the drug are that is can 
make hormone-sensitive conditions worse, as 
its mechanism of action is similar to estrogen 
(“Diindolylmethane,” n.d.).
My project asks whether drug therapies can be used 
in mice to reverse or protect from the cognitive 





hypothesis is that Donepezil can be used to treat and 
reverse the effects of radiation injury and cognitive 
damage, and my second hypothesis is that DIM can 
be used as a radioprotectant.
MATERIALS AND METHODS
In the previous behavior experiments that did not use 
a drug therapy, groups of five 4–5-week-old female 
Balb-c mice were irradiated with 30 Gy whole-brain 
radiation using an X-RAD 320 (a Cabinated radiator). 
Before radiation, the mass of each mouse was 
recorded in order to monitor its health. If the mouse 
lost too much weight, then it was euthanized. A 
control group that received no radiation was initially 
tested to set a baseline for the cognitive abilities and 
behavior patterns of a healthy mouse. After radiation, 
mice underwent behavior tests at three time points: 
4, 8, and 16 weeks. As previously mentioned, the 
behavior tests chosen were the Open Field and 
Marble Burying Tests.
In the Open Field Test, the mouse is placed in an 
artificially designed field. The field consists of a 40- 
by 40-inch plastic box with opaque walls. A camera 
was hung on an apparatus over the top of the field to 
monitor its movements, as shown in Figure 1a. The 
mouse was placed in the center of the field and allowed 
to freely roam for 20 minutes. Controls (mice not 
treated with radiation) spent an even amount of time on 
the inside, outside, corners, and middle of the field with 
a high level of ambulation. Mice that showed cognitive 
impairments postradiation spent more time on the 
outside of the field and increased ambulation indicating 
higher anxiety. Video analysis software with a Matlab 
code was used to analyze the data.
In the Marble Burying Test, 15 black nonshiny 
marbles were placed in a 3-by-5 grid in a mouse cage 
with extra bedding, as shown in Figure 1b. Mice 
were placed in the center of the cage and allowed to 
bury and move freely for 20 minutes. At the end of 
the 20 minutes, the number of marbles buried was 
counted. If a marble was at least 50% covered by the 
bedding, it was counted as buried. Control groups 
were used to set a baseline range of how many 
marbles a healthy mouse buried (11 marbles) to use 
as comparison. Mice postradiation with cognitive 
impairments buried significantly fewer marbles.
For this project the same procedure was followed 
exactly, only with the addition of drug therapies. In 
the first experiment Donepezil was used. Starting 
right after radiation, 5 mg/ml or 50 mg/kg of body 
weight of Donepezil was administered five times 
a week intraperitonealy to try to treat the radiation 
damage. After radiation and during Donepezil 
treatments, at 4 weeks and 8 weeks postradiation the 
mouse underwent both the Open Field Test and the 
Marble Burying Test. In the second experiment, 5 mg/
ml of DIM was administered 30–40 minutes before 
radiation. The allotted time was to allow the drug to 
spread throughout the body and cross the blood-brain 
barrier. The mice were also tested at 4 and 8 weeks 
postradiation with the behavior tests. The sample size 
for the controls was 13, mice treated with Donepezil 
was 5, and mice treated with DIM was 7.
Qualitative observations were taken throughout the 
entirety of the experiments, and quantitative data 
was recorded and analyzed by a one-way ANOVA 
Figure 1. (A) Open Field Test apparatus. A mouse is 
dropped into the center of the field and allowed to move 
freely for 20 minutes. Movements of the mouse are tracked 
with an overhanging camera and analyzed with a Matlab 
software. (B) Marble Burying Test apparatus. A mouse is 
dropped into a cage with 15 marbles (3 rows of 5). Each 
mouse is given 20 minutes to bury the marbles. Normal 
behavior of a healthy mouse is to bury around 11 marbles.
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Dunnett and Bonferroni statistical analysis. Averages 
of thigmotaxis and ambulation were compared, as 
were the medians of the number of marbles buried. 
The significant p-value chosen for difference between 
groups was 0.05.
RESULTS
From the Matlab code analyzing the video of the 
Open Field Test, a heat map was produced in one 
image and a line trace of all of the movements 
of the mouse during the 20 minutes in the open 
field in another image. For the images produced 
following the line of movement for the mouse, the 
image contains two red boxes: one to differentiate 
what was considered the inner quadrant and the 
other to differentiate what was considered the 
outer quadrant. This distinction was important 
in analyzing thigmotaxis, a ratio of the time the 
mouse spent on the outside divided by the total time. 
Thigmotaxis is a useful measure of anxiety, as an 
increased thigmotaxis is associated with increased 
anxiety in those mice with cognitive impairments. 
Figures 2a–c show the movement tracings of the 
mice that received only radiation and no treatment, 
and below that in Figures 2d–g are the movement 
Figure 2. Open Field Test Results. Images show the movements of a sample 
mouse from each group represented by line tracings. The red boxes distinguish 
the outer quadrant from the inner. These parameters were used to calculate 
thigmotaxis, a ratio of time spent in the outside quadrant compared to total 
time spent in both, a measure of mouse anxiety. 2a–c: Control group before 
radiation and mice 4 and 8 weeks postradiation with no treatment. 2d–e: 
Results of mice at 4 and 8 weeks postradiation treated with Donepezil. 2f–g: 












tracings of the mice that received Donepezil and 
DIM treatments.
Based on the qualitative observations of these 
movement tracings, the pictures of the mice treated 
with Donepezil looked very similar to those of the 
mice at 8 weeks that did not receive any treatment. 
There are many lines pointing to the corners, 
indicating that the mice spent more time on the 
outside. At 4 weeks postradiation, the DIM pictures 
looked similar to the 4 weeks with no treatment 
pictures. However, the 8-week postradiation picture 
looked more similar to the control that received no 
radiation, as the movement appears to spread evenly 
throughout the field.
To quantitatively analyze the Open Field Test data, 
a statistical analysis was performed on the data 
generated by the video Matlab code. Two important 
measures were used to observe the differences 
between the controls and the treated mice: average 
total ambulation and average thigmotaxis. Figures 
3 and 4 show the results of the Open Field Test 
quantitative analysis.
In Figure 3, all the groups were statistically 
significantly different from the control. Ideally, the 
treatment groups would not be different from the 
control, as the control is the baseline for a healthy 
mouse. For average total ambulation, at 4 weeks 
the treatments did not look different from the group 
that did not receive a drug therapy. At 8 weeks, the 
same amount of average ambulation was maintained 
for both drug therapies. Donepezil appeared to be 
getting closer to the control as time went on but 
was not close enough to be statistically significant. 
In Figure 4, the average thigmotaxis for both DIM 
and Donepezil was not significantly different from 
the control, indicating that anxiety might have been 
decreased in the mice. However, by 8 weeks only 
the DIM therapy maintained a statistically similar 
thigmotaxis. So, it is possible that DIM, based on 
this graph, could potentially have protected against 
the radiation damage. Donepezil might have treated 
a little bit of the damage, as observed in the average 
total ambulation and average thigmotaxis, but the 
therapy was not as effective as the deficits became 
more pronounced. It was noticed that total average 
ambulation might not be an accurate measure of 
cognitive health, as some mice showed anxiety 
through hyperactivity of increased movement, while 
other mice showed anxiety through little or no 
movement.
Figure 3. Graph of average total ambulation. Data is 
presented as mean with standard deviation. Blue bars show 
the control group as a comparison (n = 10) and the average 
ambulation of mice who did not receive any treatment at 4 
weeks postradiation and 8 weeks postradiation (n = 7). The 
green bar shows mice that received DIM before radiation at 
4 and 8 weeks postradiation (n = 7), and the red bars show 
mice that received Donepezil treatments after radiation  
(n = 5). ANOVA statistical analysis showed each group to  
be statistically different from the control group.
Figure 4. Graph of average thigmotaxis. Data is presented 
as mean with standard deviation. Thigmotaxis is a measure 
of mouse anxiety and is calculated by dividing the total time 
the mouse spent on the outer quadrant by the time spent 
in both the outer and inner quadrants. ANOVA statistical 
analysis showed that both groups at 4 weeks postradiation 
treated with Donepezil or DIM were very statistically similar 
to the control (p > 0.5). At 8 weeks postradiation, only the 
group treated with DIM remained statistically similar to the 
control (p > 0.05).
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For the Marble Burying Test a significant number 
of outliers were observed, as some groups were 
consistent, while others contained many individuals 
who varied greatly in the number of marbles they 
buried. Therefore, the median was chosen as the 
appropriate means of comparison between the 
groups. Figure 5 shows the quantitative results of the 
Marble Burying Test. The median absolute deviation 
was used to draw error bars.
Figure 5 shows that DIM was the only effective 
therapy that actually showed improvements from 
the group that received no treatment. The use of 
Donepezil actually worsened the effects of the 
cognitive damage, as mice treated with this drug 
performed much more poorly on the test. From a 
qualitative perspective, it was noted that the mice 
treated with DIM seemed to be much more mobile, 
active, and healthy than the mice who did not 
receive treatment. Those mice that were treated 
with Donepezil were less mobile and active overall 
and seemed sicker. Their overall manner was 
more similar to the mice with significant cognitive 
damage that received no treatment and did not bury 
very many marbles.
DISCUSSION OF THE RESULTS
After collecting and analyzing all of the data from 
the Open Field Test and the Marble Burying Test and 
comparing it to the control groups that received no 
treatment, it was apparent that individual variation 
played a large role in the data. A larger sample size 
could decrease this variation. Despite the noisy data, 
the results shown did increase knowledge about what 
kind of drug might work best to protect from or treat 
the brain following radiation damage.
The Open Field Test showed that Donepezil might have 
been a little effective at reducing anxiety initially but 
was not strong enough to fight the worsening cognitive 
impairment. DIM proved more promising long-term, 
as it was able to produce a thigmotaxis similar to the 
control, implying less anxiety.
The Marble Burying Test showed that DIM was 
much better at lessening the cognitive impairment 
of the radiation damage in the mice. It is important 
to note that it did not protect the mice completely 
from the damage but did possibly slow down its onset 
or lessen the impairment. Donepezil did not show 
improvements in cognitive ability.
CONCLUSION
Donepezil proved to be an ineffective form of 
correction therapy, as it did not lessen the extent 
of radiation damage to an effective degree. In the 
Marble Burying Test, mice treated with Donepezil 
buried a much smaller proportion of the marbles 
than the control mice or even those mice who did 
not receive any treatment. Donepezil might have 
treated some damage initially as observed in the 
Open Field Test, but the therapy was not effective as 
time went on. However, both the Open Field Test and 
the Marble Burying Test showed DIM to potentially 
be an effective form of protective radiation therapy 
for pediatric cancer patients who are at risk for 
white-matter injury. In the Marble Burying Test, 
mice treated with DIM buried more marbles than 
the mice that received no treatment. The most 
promising indicator of DIM’s potential or of drug 
therapies whose mechanism is similar to DIM’s 
was the qualitative observations. If DIM was able 
to improve the overall health for most mice, then it 
might be protecting from more radiation damage and 
cognitive impairment than it shows quantitatively in 
the behavior tests.
Figure 5. Graph of median number of marbles buried. Data 
is presented as median with standard median absolute 
deviation to reduce the effect of outliers. Mice treated with 
DIM consistently buried more marbles than the group that 
did not receive any drug therapy and the group treated 






In the future, this experiment could be greatly 
improved with an increase in sample size. This 
would hopefully reduce the individual variability of 
the results. The lab is also planning on continuing to 
use behavior tests to further study the effectiveness 
of DIM and possibly other drugs with a similar 
radioprotectant mechanisms. The ultimate purpose of 
the research is to safely and effectively treat humans 
for and protect them from the damaging effects of 
radiation. In the next step toward clinical use, a 
mouse tumor model must be developed to investigate 
if DIM protects tumor tissue as well as healthy tissue. 
There are a few new questions that have come about 
from this research: Are there better behavioral tests 
that can show the cognitive impairment as seen 
in human patients with radiation injury? By what 
exact mechanism does DIM work? What is the most 
important factor of a radioprotectant? Does DIM 
improve the pathological injury also? Can we see 
those changes through immunohistochemistry? 
Investigating the answers to these questions is the 
next important step in furthering this research.
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